Cost-effectiveness of risk-stratified blood test monitoring strategies for adults with inflammatory conditions
Extending the interval between monitoring blood tests appears to be cost-effective with annual monitoring producing consistently good results regardless of assumptions related to risks of AEs, risk decile or treatment.
Authors
- Maarten W. Taal (ORCID: https://orcid.org/0000-0002-9065-212X)
- Hywel C Williams (ORCID: https://orcid.org/0000-0002-5646-3093)
- Matt Stevenson (ORCID: https://orcid.org/0000-0002-3099-9877)
- Georgina Nakafero (ORCID: https://orcid.org/0000-0002-3859-7354)
- Christopher P. Fox (ORCID: https://orcid.org/0000-0002-6322-9254)
- Guruprasad Padur Aithal (ORCID: https://orcid.org/0000-0003-3924-4830)
- Tim Card (ORCID: https://orcid.org/0000-0003-2555-2250)
- Abhishek Abhishek (ORCID: https://orcid.org/0000-0003-0121-4919)
Institutions
- Nottingham University Hospitals NHS Trust (GB)
- University of Nottingham (GB)
- University of Derby (GB)
- NIHR Nottingham Digestive Diseases Biomedical Research Unit (GB)
- Nottingham Biomedical Research Centre (GB)
- University of Sheffield (GB)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1093/rheumatology/keaf623
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Health Technology Assessment Programme